Risk factor
Low price volatility
Profitability factor
Very strong margins and returns
About
TTY Biopharm Company Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally. The company operates through Oncology Business Unit, Intensive Care Business Unit, Healthcare Business Unit, Export and CDMO Business Unit, and Other Business Unit segments. It offers oncology drugs under the Lipo-Dox, Lonsurf,...
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITDA, unde
Target Price
The average target price of 4105.TWO is 86 and suggests 6% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Buy
Sell